Literature DB >> 22043194

A new look at informed consent for cancer clinical trials.

Allison R Baer1, Marge Good, Lidia Schapira.   

Abstract

Informed consent is fundamental to the conduct of clinical trials. Prospective participants need to be adequately informed and given the opportunity to ask questions and consult with relatives or friends without feeling pressured or rushed.

Entities:  

Year:  2011        PMID： 22043194      PMCID： PMC3140452          DOI： 10.1200/JOP.2011.000347

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


  12 in total

1.  Informed consent documents: increasing comprehension by reducing reading level.

Authors:  Daniel R Young; Donald T Hooker; Fred E Freeberg
Journal:  IRB       Date:  1990 May-Jun

2.  Enhancing comprehension of information for informed consent: a review of empirical research.

Authors:  Mary Cipriano Silva; Jeanne Merkle Sorrell
Journal:  IRB       Date:  1988 Jan-Feb

3.  Clinical research in low-literacy populations: using teach-back to assess comprehension of informed consent and privacy information.

Authors:  Sunil Kripalani; Rachel Bengtzen; Laura E Henderson; Terry A Jacobson
Journal:  IRB       Date:  2008 Mar-Apr

4.  Identifying patient information needs about cancer clinical trials using a Question Prompt List.

Authors:  Richard F Brown; Elyse Shuk; Phyllis Butow; Shawna Edgerson; Martin H N Tattersall; Jamie S Ostroff
Journal:  Patient Educ Couns       Date:  2010-08-02

5.  Use of a modified informed consent process among vulnerable patients: a descriptive study.

Authors:  Rebecca L Sudore; C Seth Landefeld; Brie A Williams; Deborah E Barnes; Karla Lindquist; Dean Schillinger
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

6.  Prognostic communication preferences of migrant patients and their relatives.

Authors:  D Mitchison; P Butow; M Sze; L Aldridge; R Hui; J Vardy; M Eisenbruch; R Iedema; D Goldstein
Journal:  Psychooncology       Date:  2011-02-23       Impact factor: 3.894

7.  Unrealistic optimism in early-phase oncology trials.

Authors:  Lynn A Jansen; Paul S Appelbaum; William M P Klein; Neil D Weinstein; William Cook; Jessica S Fogel; Daniel P Sulmasy
Journal:  IRB       Date:  2011 Jan-Feb

8.  Influence of clinical communication on patients' decision making on participation in clinical trials.

Authors:  Terrance L Albrecht; Susan S Eggly; Marci E J Gleason; Felicity W K Harper; Tanina S Foster; Amy M Peterson; Heather Orom; Louis A Penner; John C Ruckdeschel
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

9.  American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.

Authors:  Robin Zon; Neal J Meropol; Robert B Catalano; Richard L Schilsky
Journal:  J Clin Oncol       Date:  2008-04-07       Impact factor: 44.544

10.  The impact of language barriers on documentation of informed consent at a hospital with on-site interpreter services.

Authors:  Yael Schenker; Frances Wang; Sarah Jane Selig; Rita Ng; Alicia Fernandez
Journal:  J Gen Intern Med       Date:  2007-11       Impact factor: 5.128
View more
  3 in total

1.  Building an Informed Consent Tool Starting with the Patient: The Patient-Centered Virtual Multimedia Interactive Informed Consent (VIC).

Authors:  Fuad Abujarad; Sandra Alfano; Tiffani J Bright; Sneha Kannoth; Nicole Grant; Matthew Gueble; Peter Peduzzi; Geoffrey Chupp
Journal:  AMIA Annu Symp Proc       Date:  2018-04-16

2.  Perceptions and needs of women with metastatic breast cancer: a focus on clinical trials.

Authors:  Zeina A Nahleh; Nancy U Lin; Antonio C Wolff; Fatima Cardoso
Journal:  Breast       Date:  2013-03-25       Impact factor: 4.380

3.  "Ultimately, mom has the call": Viewing clinical trial decision making among patients with ovarian cancer through the lens of relational autonomy.

Authors:  Gladys B Asiedu; Jennifer L Ridgeway; Katherine Carroll; Aminah Jatoi; Carmen Radecki Breitkopf
Journal:  Health Expect       Date:  2018-04-14       Impact factor: 3.377
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.